Star Imaging and Path Lab (STARIMAGIN) Share Price Falls 8.40% Today
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Star Imaging and Path Lab Share Price fell to Rs 74.65 today, down 8.40% from the previous close of Rs 81.5, while the company’s market capitalisation stood at Rs 135.86 crore. The move makes Star Imaging and Path Lab Stock News relevant for readers tracking today’s decline in a Micro Cap company within healthcare services.
The session opened at Rs 80 and touched the same level as the day’s high before sliding to a low of Rs 74.65, which also became the closing price. The data confirms the price event, but it does not establish a company-specific catalyst. In that context, the Star Imaging and Path Lab Share Price Today move is best read as a factual market update rather than a reason-led event. Univest is covering the decline through a price-action lens, along with valuation, sector context and peer comparison so readers can place the latest Star Imaging and Path Lab Stock News in a broader framework.
Star Imaging and Path Lab (STARIMAGIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 74.65 |
| Previous Close | Rs 81.5 |
| Today's Move | -Rs 6.85 (-8.4%) |
| Open | Rs 80 |
| High | Rs 80 |
| Low | Rs 74.65 |
| Turnover | Rs 0.16 crore |
| Market Capitalisation | Rs 135.86 crore |
| Market Cap Category | Micro Cap |
Star Imaging and Path Lab Share Price Today showed a clear intraday decline. The stock opened at Rs 80, matched its high at Rs 80, and then moved lower through the session to Rs 74.65, which was also the low and the close. Compared with the previous close of Rs 81.5, the share price fell Rs 6.85, or 8.40%, in one day. That is the central fact behind today’s Star Imaging and Path Lab Share Price fall.
Turnover for the session was Rs 0.16 crore. The company is classified as a Micro Cap, and the market capitalisation of Rs 135.86 crore places it within that category. For readers following Star Imaging and Path Lab Share News, the day’s pattern shows that the stock ended below its opening level and below the prior close, with no intraday recovery back to the open. Univest tracks this kind of price action because it helps separate the event itself from any speculation about why it happened. On the supplied data, the share price decline is confirmed, while a company-specific trigger is not established. That leads naturally into the valuation and fundamentals behind the move.
Star Imaging and Path Lab (STARIMAGIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 135.86 crore |
| P/E Ratio | 7.36x |
| P/B Ratio | 1.23x |
| ROE | 40.65% |
| ROCE | 33.81% |
| EPS | Rs 11.07 |
| Book Value Per Share | Rs 66.39 |
| Dividend Yield | 0% |
The fundamental picture gives the Star Imaging and Path Lab Share Price some context. The stock trades at a P/E ratio of 7.36 and a P/B ratio of 1.23, both based on the supplied figures. EPS stands at Rs 11.07, which reflects earnings attributable to each share, while book value is Rs 66.39 per share. Dividend yield is 0, so the current data does not indicate a dividend return factor.
Profitability ratios are notable in the supplied set. ROE is 40.65 and ROCE is 33.81, both of which are meaningfully above the benchmark medians shown later in the article. Market capitalisation is Rs 135.86 crore, and the stock’s valuation profile appears materially different from several listed healthcare peers in the same industry. That does not explain today’s decline, but it does help frame the Star Imaging and Path Lab Share Price Today discussion for investors reviewing Star Imaging and Path Lab Stock Analysis. Univest uses these exact figures to present a factual fundamental lens rather than a forecast.
Because no separate revenue, net profit or leverage figures are supplied here, the analysis remains centered on the verified multiples and per-share metrics. Even so, the combination of low P/E, modest P/B, strong ROE and strong ROCE is enough to make Star Imaging and Path Lab Share News relevant for those comparing valuation with operating quality. The next useful layer is ownership structure.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 7.36x |
| Benchmark Median P/E | 46.3x |
| Benchmark Average P/E | 99.59x |
| Benchmark P/E Range | 7.36x to 1,593x |
| Company P/B Ratio | 1.23x |
| Benchmark Median P/B | 3.93x |
| Benchmark Average P/B | 4.64x |
| Company ROE | 40.65% |
| Benchmark Median ROE | 13.23% |
| Benchmark Average ROE | 14.03% |
| Company ROCE | 33.81% |
| Benchmark Median ROCE | 16% |
| Benchmark Average ROCE | 3.77% |
| Company Market Capitalisation | Rs 135.86 crore |
| Benchmark Median Market Cap | Rs 486 crore |
| Benchmark Average Market Cap | Rs 11,353.19 crore |
Star Imaging and Path Lab operates in Healthcare, within the Hospital & Healthcare Services industry. The supplied benchmark set covers the same industry and includes 65 companies, which gives a useful scope for comparison. On the exact numbers provided, Star Imaging and Path Lab Share Price is tied to a company P/E of 7.36 versus a sector median P/E of 46.3 and a sector average P/E of 99.59. That places the stock well below both the median and average on valuation multiples.
The company’s P/B ratio of 1.23 also sits below the industry median P/B of 3.93 and the average of 4.64. ROE at 40.65 is above the sector median of 13.23, while ROCE at 33.81 is above the sector median of 16. The market-cap context is also relevant: the industry median market capitalisation is Rs 486 crore, while Star Imaging and Path Lab’s market capitalisation is Rs 135.86 crore. This keeps the stock below the median market size in the benchmark set. For investors reading Star Imaging and Path Lab Stock News, the comparison is straightforward: the company looks inexpensive on P/E and P/B relative to the sector, while profitability ratios are stronger than the median industry figures.
The company also sits in a sector where benchmark outcomes vary widely. The same industry sample shows a P/E range from 7.36 to 1593 and a P/B range from -9.39 to 15.27. Against that backdrop, Univest’s sector analysis shows the stock as a low-multiple name in a broad healthcare universe, but today’s share price fall is still a separate event from valuation itself. Investors typically use such comparisons to understand how today’s Star Imaging and Path Lab Share Price aligns with the wider Hospital & Healthcare Services group.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise | APOLLOHOSP | 1,25,092.65 | 59.96 | 12.94 | 23.54 | 21.73 |
| Max Healthcare Institute | MAXHEALTH | 99,963.83 | 68.98 | 9.2 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 92,339.48 | 105.32 | 5.15 | 12.95 | 13.93 |
| Fortis Healthcare | FORTIS | 66,360.82 | 62.57 | 6.45 | 11.32 | 14.07 |
| Aster DM Healthcare | ASTERDM | 64,704.25 | 202.67 | 15.27 | 13.07 | 16.22 |
Among the supplied peers, Star Imaging and Path Lab Share Price stands out on valuation and size. Its P/E of 7.36 is lower than Apollo Hospitals Enterprise at 59.96, Max Healthcare Institute at 68.98, Manipal Health Enterpri L at 105.32, Fortis Healthcare at 62.57 and Aster DM Healthcare at 202.67. That makes the stock the lowest-P/E name in the peer set provided.
On ROE, the company’s 40.65 is above Apollo Hospitals at 23.54, Max Healthcare at 14.53, Manipal Health Enterpri L at 12.95, Fortis Healthcare at 11.32 and Aster DM Healthcare at 13.07. ROCE at 33.81 is also above Apollo Hospitals at 21.73, Max Healthcare at 14.97, Manipal Health Enterpri L at 13.93, Fortis Healthcare at 14.07 and Aster DM Healthcare at 16.22. In market-cap terms, Star Imaging and Path Lab at Rs 135.86 crore is much smaller than each of those peers. Univest presents this peer view to help readers judge the stock’s relative valuation and profitability, even as today’s decline remains an event-specific price move rather than a peer-driven conclusion.
Why Investors Are Watching Star Imaging and Path Lab
- Star Imaging and Path Lab Share Price fell 8.40% today to Rs 74.65, compared with the previous close of Rs 81.5.
- The stock opened at Rs 80, touched a high of Rs 80 and a low of Rs 74.65 during the session.
- Market capitalisation is Rs 135.86 crore, placing the company in the Micro Cap category.
- P/E is 7.36, P/B is 1.23, EPS is Rs 11.07 and book value is Rs 66.39 per share.
- ROE is 40.65 and ROCE is 33.81, both above the supplied industry medians.
About Star Imaging and Path Lab
Star Imaging and Path Lab is classified in Healthcare and operates in the Hospital & Healthcare Services industry. The supplied company profile in this update is to this sector and industry classification, along with the market data and valuation metrics discussed above. For readers following Star Imaging and Path Lab Share News, that means the analysis here stays firmly anchored to verified figures rather than broader assumptions about the business model.
In Univest’s coverage, the company is best viewed through its listed-market data: today’s price move, market capitalisation, earnings metrics and sector positioning. The current Star Imaging and Path Lab Share Price Today update is therefore a fact-based market note, not a projection about business performance or future stock direction.
Track Star Imaging and Path Lab Share Price on Univest
Use Star Imaging and Path Lab (STARIMAGIN) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Star Imaging and Path Lab Share Price on Univest for live updates, valuation ratios, shareholding pattern, 52-week levels and market insights. The platform also brings together Star Imaging and Path Lab Stock Analysis, Star Imaging and Path Lab Financial Results and sector context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Star Imaging and Path Lab Share Price falling today?
Ans. The supplied data confirms that Star Imaging and Path Lab Share Price fell 8.40% to Rs 74.65 today. It does not establish a company-specific catalyst, so the move should be treated as a verified price event.
What is Star Imaging and Path Lab Share Price today?
Ans. Star Imaging and Path Lab Share Price today is Rs 74.65. The stock closed below its previous close of Rs 81.5 after opening at Rs 80 and touching the same level as its intraday high.
How much did Star Imaging and Path Lab stock fall today?
Ans. Star Imaging and Path Lab stock fell Rs 6.85, or 8.40%, from the previous close. The share price moved from Rs 81.5 to Rs 74.65 in today’s session. The previous close was Rs 81.5.
What is the market capitalisation of Star Imaging and Path Lab?
Ans. The market capitalisation of Star Imaging and Path Lab is Rs 135.86 crore. The stock is classified as a Micro Cap in the supplied data, which provides company-size context for today’s share price update.
How does Star Imaging and Path Lab compare with healthcare peers?
Ans. Star Imaging and Path Lab has a lower P/E than the supplied healthcare peers and a smaller market capitalisation than each of them. Its ROE and ROCE are higher than the peer figures shown in the dataset.
What do the valuation ratios say about Star Imaging and Path Lab Share Price?
Ans. Star Imaging and Path Lab Share Price sits alongside a P/E of 7.36 and P/B of 1.23. Those figures are below the provided industry medians, while EPS is Rs 11.07 and book value is Rs 66.39.
